TD Ameritrade Investment Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

TD Ameritrade Investment Management’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-22	Closed	-$1K	–	546
2023 Q2	$1K	Hold	22	–	–	﹤0.01%	534
2023 Q1	$1K	Hold	22	–	–	﹤0.01%	583
2022 Q4	$1K	Hold	22	–	–	﹤0.01%	585
2022 Q3	$1K	Hold	22	–	–	﹤0.01%	575
2022 Q2	$2K	Sell	22 -117	-84%	-$8.55K	﹤0.01%	564
2022 Q1	$11K	Hold	139	–	–	﹤0.01%	493
2021 Q4	$14K	Buy	+139	New	+$13.3K	﹤0.01%	455

Other funds holding SYNH

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

CFB

Cullen/Frost Bankers San Antonio, Texas $10.1B AUM 29.18% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

TD Ameritrade Investment Management's SYNH Position: Q3 2023 in Review

TD Ameritrade Investment Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 22 shares — an estimated $1K sold.

TD Ameritrade Investment Management first reported a position in SYNH in Q4 2021 and held it in 7 quarters. The position peaked at $14K in Q4 2021. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

TD Ameritrade Investment Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
TD Ameritrade Investment Management sold 22 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $1K.
TD Ameritrade Investment Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2021 and held it in 7 quarters.
TD Ameritrade Investment Management's Syneos Health, Inc. Class A Common Stock position peaked at $14K in Q4 2021.
10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on TD Ameritrade Investment Management's 13F filing for Q3 2023.